Revotek Receives Clearance from the National Health Commission of China for the World First Clinical Trial for 3D Bioprinted Stem Cell Vascular Grafts



https://markets.businessinsider.com/news/stocks/revotek-receives-clearance-from-the-national-health-commission-of-china-for-the-world-first-clinical-trial-for-3d-bioprinted-stem-cell-vascular-grafts-1031212751

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.